K Number
K071036
Device Name
MODIFICATION TO ACUSON X300 ULTRASOUND SYSTEM
Date Cleared
2007-05-16

(34 days)

Product Code
Regulation Number
892.1550
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Diagnostic imaging or fluid flow analysis of the human body as follows: General Radiology, Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Neonatal/Adult Cephalic, Cardiac, Transesophageal, Pelvic, Transcranial, OB/GYN, Urology, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.
Device Description
The Siemens Acuson X300 has been designed to meet the following product safety standards: UL 60601-1, Safety Requirements for Medical Equipment; IEC 60601-2-37 Diagnostic Ultrasound Safety Standards; CSA C22.2 No. 601-1, Safety Requirements for Medical Equipment; AIUM/NEMA UD-3, Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment; AIUM/NEMA UD-2, Acoustic Output Measurement Standard for Diagnostic Ultrasound; 93/42/EEC Medical Devices Directive; Safety and EMC Requirements for Medical Equipment EN/EC 60601-1, EN/IEC 60601-1-1, EN/IEC 60601-1-2; IEC 61157 Declaration of Acoustic Power; ISO 10993-1 Biocompatibility.
More Information

Not Found

No
The document does not mention AI, ML, or related terms, and the description focuses on safety standards and predicate devices, not advanced processing techniques.

No
The "Intended Use / Indications for Use" section explicitly states "Diagnostic imaging or fluid flow analysis," which indicates a diagnostic rather than therapeutic purpose.

Yes

The "Intended Use / Indications for Use" section explicitly states "Diagnostic imaging or fluid flow analysis of the human body". Furthermore, the "Device Description" mentions compliance with "IEC 60601-2-37 Diagnostic Ultrasound Safety Standards" and "AIUM/NEMA UD-3, Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment; AIUM/NEMA UD-2, Acoustic Output Measurement Standard for Diagnostic Ultrasound".

No

The device description explicitly mentions hardware safety standards (UL 60601-1, IEC 60601-2-37, etc.) and refers to the "Siemens Acuson X300 ultrasound system," which is a hardware device. The summary also discusses verification and validation according to a design control process, which would include hardware aspects.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states "Diagnostic imaging or fluid flow analysis of the human body". This describes a device that interacts directly with the patient to produce images or analyze flow within the body.
  • Device Description: The description focuses on safety standards related to medical equipment and diagnostic ultrasound, not laboratory testing of samples.
  • Input Imaging Modality: The input modality is Ultrasound, which is a non-invasive imaging technique applied to the patient.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) in vitro (outside the body), which is the defining characteristic of an IVD.

Therefore, the Siemens Acuson X300, as described, is a diagnostic imaging device, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The Siemens Acuson X300 ultrasound imaging system is intended for the following applications: General Radiology, Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Neonatal/Adult Cephalic, Cardiac, Transesophageal, Pelvic, Transcranial, OB/GYN, Urology, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.

Product codes (comma separated list FDA assigned to the subject device)

90-IYN, 90-IYO, 90-ITX, 74-DQO

Device Description

The Siemens Acuson X300 ultrasound system is a multi-purpose diagnostic ultrasound system with accessories and proprietary software, and is substantially equivalent to our current product, the Siemens Acuson X300 ultrasound system (K061946).

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Fetal, Abdominal, Intraoperative (abdominal, vascular), Intraoperative Neurological, Pediatric, Small Organ (breast, testes, thyroid, penis, prostate, etc.), Neonatal Cephalic, Adult Cephalic, Cardiac, Transesophageal, Transrectal, Transvaginal, Intravascular, Peripheral vessel, Musculo-skeletal Conventional, Musculo-skeletal Superficial, Intra-Cardiac

Indicated Patient Age Range

Neonatal, Pediatric, Adult

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The Acuson X300 modifications are verified and validated according to the company's design control process.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K061946

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.1550 Ultrasonic pulsed doppler imaging system.

(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

SECTION 11

510(k) Summary

| Sponsor: | Siemens Medical Solutions USA, Inc.,
Ultrasound Division
1230 Shorebird Way
Mountain View, California 94043 | MAY 16 2007 |
|------------------|----------------------------------------------------------------------------------------------------------------------|-------------|
| Contact Person: | Martina Vogt | |
| Telephone: | (425) 557 1434 | |
| Fax: | (425) 391 9198 | |
| Submission Date: | April 11, 2007 | |
| Device Name: | ACUSON X300™ Diagnostic Ultrasound System
SONOVISTA X300 Diagnostic Ultrasound System | |

  • Common Name: Diagnostic Ultrasound System with Accessories

Classification:

Regulatory Class:II
Review Category:Tier II
Classification Panel:Radiology
Ultrasonic Pulsed Doppler Imaging SystemFR # 892.1550Product Code 90-IYN
Ultrasonic Pulsed Echo Imaging SystemFR # 892.1560Product Code 90-IYO
Diagnostic Ultrasound TransducerFR # 892.1570Product Code 90-ITX
Diagnostic Intravascular CatheterFR # 870.1200Product Code 74-DQO

A. Legally Marketed Predicate Devices

The Siemens Acuson X300 ultrasound system is a multi-purpose diagnostic ultrasound system with accessories and proprietary software, and is substantially equivalent to our current product, the Siemens Acuson X300 ultrasound system (K061946).

B. Device Description:

The Siemens Acuson X300 has been designed to meet the following product safety standards:

  • 트 UL 60601-1, Safety Requirements for Medical Equipment
  • 트 IEC 60601-2-37 Diagnostic Ultrasound Safety Standards
  • 트 CSA C22.2 No. 601-1, Safety Requirements for Medical Equipment
  • 트 AIUM/NEMA UD-3, Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment
  • 프 AIUM/NEMA UD-2, Acoustic Output Measurement Standard for Diagnostic Ultrasound
  • . 93/42/EEC Medical Devices Directive
  • 바 Safety and EMC Requirements for Medical Equipment
    • EN/EC 60601-1
    • EN/IEC 60601-1-1
    • 트 EN/IEC 60601-1-2

1

  • 유 IEC 61157 Declaration of Acoustic Power
  • ISO 10993-1 Biocompatibility

C. Intended Use

The Siemens Acuson X300 ultrasound imaging system is intended for the following applications: General Radiology, Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Neonatal/Adult Cephalic, Cardiac, Transesophageal, Pelvic, Transcranial, OB/GYN, Urology, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.

D. Substantial Equivalence

The submission device is substantially equivalent to the predicate with regard to both intended use and technological characteristics.

E. Performance Data

The Acuson X300 modifications are verified and validated according to the company's design control process.

2

Image /page/2/Picture/2 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized eagle with its wings spread, symbolizing protection and care. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle, indicating the department's name and national affiliation. The seal is presented in black and white, emphasizing its official and formal nature.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Martina Vogt Regulatory Affairs Specialist Siemens Medical Solutions USA, Inc. 1230 Shorebird Way MOUNTAIN VIEW CA 94043

MAY 16 2007

Re: K071036

Trade Name: ACUSON X300 Diagnostic Ultrasound Systems Regulation Number: 21 CFR §892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX and DQO Dated: April 11, 2007 Received: April 16, 2007

Dear Ms. Vogt:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the ACUSON X300 Diagnostic Ultrasound Systems, as described in your premarket notification:

Transducer Model Number

P4-2 Phased Sector Array CH5-2 Convex Array VF10-5 Linear Array L9-5 Linear Array EC9-4 Convex Array EV9-4 Convex Array VF13-5 Linear Array P8-4 Phased Array BE9-4 Convex Array CW2 Continuous Wave Doppler CW5 Continuous Wave Doppler Acu Nav 8F Intracardiac

Acu Nav 10F Intracardiac V5Ms TEE 4V1c Phased Array VF13-5SP Linear Array C8-5 Tight Curved Array 8L3 Linear "Regel" 10V4 Phased Array Neonatal High Frequency C7F2 Curved Array Mechanical 3D/4D EV9F4 Curved Array Mechanical 3D/4D L13F5 3D/4D Mechanical Wobbler Linear VF8-3 Linear

3

Page 2 - Ms. Martina Vogt

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), if your device is classified (dos are controls. Existing major regulations affecting your device It may be subject to sach as Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean I Tease be advised that I DTT official of our device complies with other requirements of the Act that I Drinas Intatutes and regulations administered by other Federal agencies. You must of any I coural statutes and regerments, including, but not limited to: registration and listing (21 comply with an the 10th 3 requirements, More, and manufacturing practice requirements as set CFN in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.

This determination of substantial equivalence is granted on the condition that prior to shipping I ms device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested information, merculing acounts of the Center's September 30, 1997 "Information for Manufacturers In Appendix U, (encrosou) of the Senter tic Ultrasound Systems and Transducers." If the special Secking Manching Cloudins unaceptable values (e.g., acoustic output greater than approved report is incomplete or comains anaooopation faract (organisation units which as a result may be considered adulterated or misbranded.

The special report should réference the manufacturer's 510(k) number. It should be clearly and The special report should be submitted in designitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket This letter will anow you to begin marketing your device to a legally marketed notification. The I Driving of succion for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you dosire specific advision at (240) 276-0120. Also, please note the regulation entitled, Contact the Office of Oremarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general informational and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

4

Page 3 – Ms. Martina Vogt

If you have any questions regarding the content of this letter, please contact Paul Hardy at (240) 276-3666.

Sincerely yours,

Nancy C Brogdon
Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosures

5

510(k) Number (if known):

ACUSON X300 Diagnostic Ultrasound Systems

Device Name:

Intended Use:

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)PPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
NeurologicalPPPPPBMDCNote 2,3,4,5,7,8,9
PediatricPPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
Adult CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
CardiacPPPPPPBMDCNote 2,3,4,5,7,8,9
TransesophagealPPPPPPBMDCNote 2,3,7,8,9
TransrectalPPPPPBMDCNote 2,3,4,5,7,8,9
TransvaginalPPPPPBMDCNote 2,3,4,5,7,8,9
Transurethral
IntravascularPPPPPPBMDCNote 2,3,7,8,9,10
Peripheral vesselPPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)PPPPPPBMDCNote 2,3,7,8,9,10

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

B&W SieScape panoramic imaging Note 4

Note 5 Power SieScape panoramic imaging

For example: abdominal, vascular Note 6

Note 7 , Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)Nancy C Brogdon
Prescription Use (Per 21 CFR 801.109) (Division Sign-Off)Division of Reproductive, Abdominal, and Radiological Devices
510(k) NumberK071036

Pg. 6.2 of 6.25Diagnostic Ultrasound Indications for Use Form

Pg. 6.2 of 6.25

6

510(k) Number (if known):

Device Name:

P4-2 Phased Sector Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems

Intended Use:

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPPBMDCNote 2,3,5,6,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)
Neonatal CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
Adult CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
CardiacPPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Noțe 2 Ensemble tissue harmonic imaging

3D imaqing Note 3

B&W SieScape panoramic imaging Note 4

Power SieScape panoramic imaging Note 5

For example: abdominal, vascular Note 6

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

Diagnostic Ultrasound Indications for Use Form

Pg. 6.3 of

7

510(k) Number (if known):

Device Name:

Intended Use:

CH5-2 Convex Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)
Neonatal Cephalic
Adult Cephalic
CardiacPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Note 2 Ensemble tissue harmonic imaging

3D imaging Note 3

B&W SieScape panoramic imaging Note 4

Power SieScape panoramic imaging Note 5

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

Note 8 SieClear multi-view spatial compounding

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAC Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)

Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

8

510(k) Number (if known):

Device Name:

Intended Use:

VF10-5 Linear Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Power SieScape panoramic imaging Note 5

For example: abdominal, vascular Note 6

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF N Concurrence of CDRH, Office of Device Evaluation (ODE)

Nancy C. Broydon

Prescription Use (Per 21 CFR 801.109)

D
(Division Sign-Oft)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

Diagnostic Ultrasound Indications for Use Form

Pg. 6.5 of 6.25

9

510(k) Number (if known):

Device Name:

Intended Use:

L9-5 Linear Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Ultrasound imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2.3.4.5.7.8.9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

  • Ensemble tissue harmonic imaging Note 2
  • 3D imaging Note 3

B&W SieScape panoramic imaging Note 4

Power SieScape panoramic imaging Note 5

  • Note 6 For example: abdominal, vascular
    Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

(ODE)
Nancy C. Brogdon
(Division Sign-Off)

Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

g. 6.6 of 6.25

10

510(k) Number (if known):

Device Name:

Intended Use:

EC9-4 Convex Array Endocavity Transducer for use with: ACUSON X300 Diagnostic Uitrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation Color Clinical Application Color Amplitude Combined Other B PWD CWD Velocity A M Doppler Doppler (Specify) (Specify) Imaging Ophthalmic P P P P P BMDC Note 2,3,4,5,7,8,9 Fetal Abdominal Intraoperative (Note 6) Intraoperative Neurological Pediatric Small Organ P P P P P BMDC Note 2,3,4,5,7,8,9 (Note 1) P P Neonatal Cephalic P P P BMDC Note 2,3,4,5,7,8,9 Adult Cephalic Cardiac Transesophageal P P BMDC Note 2,3,4,5,7,8,9 Transrectal P P P Transvaginal P P P P P BMDC Note 2,3,4,5,7,8,9 Transurethral Intravascular Peripheral vessel Laparoscopic Musculo-skeletal Conventional Musculo-skeletal Superficial Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Power SieScape panoramic imaging Note 5

For example: abdominal, vascular Note 6

Contrast agent imaging Note 7

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF N Concurrence of CDRH, Office of Device Evaluation (ODE)

DE)
Nancy Broadon

Prescription Use (Per 21 CFR 801.109)

(Division Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number

Diagnostic Ultrasound Indications for Use Form

Pg. 6.7 of 6.25

11

510(k) Number (if known):

Device Name:

EV9-4 Convex Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Intended Use:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
Abdominal
Intraoperative
(Note 6)
Intraoperative
Neurological
Pediatric
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
TransrectalPPPPPBMDCNote 2,3,4,5,7,8,9
TransvaginalPPPPPBMDCNote 2,3,4,5,7,8,9
Transurethral
Intravascular
Peripheral vessel
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

B&W SieScape panoramic imaging Note 4

Power SieScape panoramic imaging Note 5

Note 6 For example: abdominal, vascular

Contrast agent imaging Note 7

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEED Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy brogdon

ictive. Abdominal, and 510(k) Num

Section 6

Diagnostic Ultrasound Indications for Use Form

Pg. 6.8 of 6.25

12

510(k) Number (if known): .

Device Name:

Intended Use:

VF13-5 Linear Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2.3.4.5.7.8.9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

B&W SieScape panoramic imaging Note 4

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Contrast agent imaging Note 7

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sign Off)

BrogdonPrescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

13

510(k) Number (if known):

Device Name:

Intended Use:

P8-4 Phase Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPPBMDCNote 2,3,45,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)
Neonatal CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
CardiacPPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

  • Ensemble tissue harmonic imaging Note 2
  • 3D imaging Note 3
  • Note 4 B&W SieScape panoramic imaging
  • Power SieScape panoramic imaging Note 5
  • For example: abdominal, vascular Note 6
  • Note 7 Contrast agent imaging
  • Note 8 SieClear multi-view spatial compounding
  • Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
----------------------------------------------------------

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

Diagnostic Ultrasound Indications for Use Form

Pg. 6.10 of 6.25

14

510(k) Number (if known):

Device Name:

Intended Use:

BE9-4 Convex Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
Abdominal
Intraoperative
(Note 6)
Intraoperative
Neurological
Pediatric
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
TransrectalPPPPPBMDCNote 2,3,4,5,7,8,9
TransvaginalPPPPPBMDCNote 2,3,4,5,7,8,9
Transurethral
Intravascular
Peripheral vessel
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaging

B&W SieScape panoramic imaging Note 4

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

Note 8 SieClear multi-view spatial compounding

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Hogdon

(Division Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number

Section 6

15

510(k) Number (if known):

Device Name:

Intended Use:

CW2 Continuous Wave Doppler Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
ABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalP
AbdominalP
Intraoperative
(Note 6)P
Intraoperative
Neurological
PediatricP
Small Organ
(Note 1)P
Neonatal CephalicP
Adult CephalicP
CardiacP
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselP
Laparoscopic
Musculo-skeletal
ConventionalP
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Contrast agent imaging Note 7

Note 8 SieClear multi-view spatial compounding

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C Brogdon

(Division S Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number

Section 6

Diagnostic Ultrasound Indications for Use Form

Pg. 6.12 of 6.25

16

510(k) Number (if known):

Device Name:

Intended Use:

CW5Continuous Wave Doppler Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalP
AbdominalP
Intraoperative
(Note 6)P
Intraoperative
Neurological
PediatricP
Small Organ
(Note 1)P
Neonatal CephalicP
Adult CephalicP
CardiacP
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselP
Laparoscopic
Musculo-skeletal
ConventionalP
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

  • Note 2 Ensemble tissue harmonic imaging
  • 3D imaging Note 3
  • B&W SieScape panoramic imaging Note 4
  • Note 5 Power SieScape panoramic imaging
  • For example: abdominal, vascular Note 6
  • Note 7 Contrast agent imaging
  • SieClear multi-view spatial compounding Note 8
  • Tissue Equalization Technology Note 9
  • Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
----------------------------------------------------------

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number
K071036

V an

Diagnostic Ultrasound Indications for Use Form

Pg. 6.13 of 6.25

17

510(k) Number (if known):

Device Name:

Intended Use:

Acu Nav 8F Intracardiac Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Diagnostic, imaging or fluid flow analysis of the human body as follows.

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(Note 6)
Intraoperative
Neurological
Pediatric
Small Organ
(Note 1)
Neonatal Cephalic
Adult Cephalic
CardiacPPPPPPPBMDCNote 2,3,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
IntravascularPPPPPPPBMDCNote 2,3,7,8,9,10
Peripheral vessel
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Intra-cardiac)PPPPPPPBMDCNote 2,3,7,8,9,10

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Ensemble tissue harmonic imaging Note 2

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Contrast agent imaging Note 7

Note 8 SieClear multi-view spatial compounding

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)Muat
--------------------------------------------------------------

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

18

510(k) Number (if known):

Device Name:

Intended Use:

Acu Nav 10F Intracardiac Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(Note 6)
Intraoperative
Neurological
Pediatric
Small Organ
(Note 1)
Neonatal Cephalic
Adult Cephalic
CardiacPPPPPPPBMDCNote 2,3,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
IntravascularPPPPPPPBMDCNote 2,3,7,8,9,10
Peripheral vessel
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Intra-cardiac)PPPPPPPBMDCNote 2,3,7,8,9,10

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaqing

Note 4 B&W SieScape panoramic imaging

Power SieScape panoramic imaging Note 5

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

Note 8 SieClear multi-view spatial compounding

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy Modon

(Division Sign-Off)

Division of Reproductive, Abdominal, and
Radiological Devices

Pg. 6.15 of 6.25

510(k) Number

19

510(k) Number (if known):

Device Name:

Intended Use:

V5Ms TEE Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation Color Clinical Application Amplitude Combined Color Other B PWD CWD Velocity A M Doppler Doppler (Specify) (Specify) Imaging Ophthalmic Fetal Abdominal Intraoperative (Note 6) Intraoperative Neurological Pediatric Small Organ (Note 1) Neonatal Cephalic Adult Cephalic Cardiac P P P P P P BMDC Note 2,3,7,8,9 Transesophageal Transrectal Transvaginal Transurethral Intravascular Peripheral vessel Laparoscopic Musculo-skeletal Conventional Musculo-skeletal Superficial Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Ensemble tissue harmonic imaging Note 2

3D imaging Note 3

Note 4 B&W SieScape panoramic imaging

Power SieScape panoramic imaging Note 5

For example: abdominal, vascular Note 6

Contrast agent imaging Note 7

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy Brogdon

oductive. Abdominal, a 510(k) Number

Section 6

Diagnostic Ultrasound Indications for Use Form

Pg. 6.16 of 6.25

20

510(k) Number (if known):

Device Name:

Intended Use:

4V1c Phased Array Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPPBMDCNote 2,3,5,6,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)
Neonatal CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
Adult CephalicPPPPPPBMDCNote 2,3,4,5,7,8,9
CardiacPPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDE Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Sign-off vragen

(Division Sign-Off)

Division of Reproductive Abd

Division of Reproductive. Abdominal. Raciological Device 510(k) Number

Diagnostic Ultrasound Indications for Use Form

Pg. 6.17 of 6.

21

510(k) Number (if known):

Device Name:

VF13-5SP Linear array Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems

Intended Use:

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(Note 6)PPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
NeurologicalPPPPPBMDCNote 2,3,4,5,7,8,9
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Ensemble tissue harmonic imaging Note 2

3D imaging Note 3

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

For example: abdominal, vascular Note 6

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Note 9 Tissue Equalization Technology

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)Nancyc broodon
Prescription Use (Per 21 CFR 801.109)(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) NumberR071036

Section 6 Diagnostic Ultrasound Indications for Use Form Pg. 6.18 of 6.25

22

510(k) Number (if known):

Device Name:

Intended Use:

C8-5 Tight Curved Array Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPBMDCNote 2,3,5,6,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
CardiacPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

  • Note 2 Ensemble tissue harmonic imaging
  • Note 3 3D imaging
  • Note 4 B&W SieScape panoramic imaging
  • Note 5 Power SieScape panoramic imaging
  • Note 6 For example: abdominal, vascular
  • Note 7 Contrast agent imaging
  • Note 8 SieClear multi-view spatial compounding
  • Note 9 Tissue Equalization Technology
  • Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nanay C. bradon

(Division Sign-Off)
Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

Pg. 6.19 or 6.25

23

510(k) Number (if known):

Device Name:

Intended Use:

8L3 Linear "Regel" Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation Color Clinical Application Amplitude Color Combined Other A B PWD CWD Velocity M Doppler Doppler (Specify) (Specify) Imaging Ophthalmic Fetal P P P P P BMDC Note 2,3,4,5,7,8,9 P p Abdominal P P P BMDC Note 2,3,4,5,7,8,9 Intraoperative (Note 6) Intraoperative Neurological Pediatric P P P P P BMDC Note 2,3,4,5,7,8,9 Small Organ P P P P P BMDC Note 2,3,4,5,7,8,9 (Note 1) P P P Neonatal Cephalic P P BMDC Note 2,3,4,5,7,8,9 Adult Cephalic Cardiac Transesophageal Transrectal Transvaginal Transurethral Intravascular Peripheral vessel P P P P P BMDC Note 2,3,4,5,7,8,9 Laparoscopic Musculo-skeletal P P P P P BMDC Note 2,3,4,5,7,8,9 Conventional Musculo-skeletal P P P P P BMDC Note 2,3,4,5,7,8,9 Superficial

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

  • Note 2 Ensemble tissue harmonic imaging
  • 3D imaging Note 3

Other (specify)

  • Note 4 B&W SieScape panoramic imaging
  • Power SieScape panoramic imaging Note 5
  • For example: abdominal, vascular Note 6
  • Note 7 Contrast agent imaqing
  • SieClear multi-view spatial compounding Note 8
  • Tissue Equalization Technology Note 9
  • Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Hoagdon

of Reproductive, Abdominal, a 510(k) Numbe

Pg. 6.20 of 6.25

24

510(k) Number (if known):

Device Name:

Intended Use:

10V4 Phased Array Neonatal High Frequency Transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation Color Clinical Application Amplitude Color Combined Other A B PWD CWD M Velocity Doppler Doppler (Specify) (Specify) Imaging Ophthalmic P P P Fetal P P P BMDC Note 2,3,4,5,7,8,9 P Abdominal P P b P P BMDC Note 2,3,45,7,8,9 Intraoperative (Note 6) Intraoperative Neurological Pediatric P P P P P P BMDC Note 2,3,4,5,7,8,9 Small Organ (Note 1) P P P Neonatal Cephalic P P P BMDC Note 2,3,4,5,7,8,9 Adult Cephalic Cardiac P P P P P P BMDC Note 2,3,4,5,7,8,9 Transesophageal Transrectal Transvaginal Transurethral Intravascular P Peripheral vessel P P P P P BMDC Note 2,3,4,5,7,8,9 Laparoscopic Musculo-skeletal P P P P P P BMDC Note 2,3,4,5,7,8,9 Conventional Musculo-skeletal Superficial Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

  • Note 2 Ensemble tissue harmonic imaging
  • Note 3 3D imaging
  • B&W SieScape panoramic imaging Note 4
  • Note 5 Power SieScape panoramic imaging
  • For example: abdominal, vascular Note 6
  • Note 7 Contrast agent imaging
  • SieClear multi-view spatial compounding Note 8
  • Tissue Equalization Technology Note 9
  • Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Brogdon

(Division Sign-pm)

Division of Reproductive, Abdominal, and
Radiological Devices
510(k) Number K071036

Pg. 6.21 of 6.25

25

510(k) Number (if known):

Device Name:

C7F2 Curved array mechanical 3D/4D Transducer for use with : ACUSON X300 Diagnostic Ultrasound Systems

Intended Use:

Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)
Neonatal Cephalic
Adult Cephalic
CardiacPPPPPBMDCNote 2,3,4,5,7,8,9
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Note 2 Ensemble tissue harmonic imaging

3D imaging Note 3

B&W SieScape panoramic imaging Note 4

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

Note 8 SieClear multi-view spatial compounding

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE

Prescription Use (Per 21 CFR 801.109)

Nancy Chuyalon
Division Sign-Off

oductive. Abdominal, 510(k

Pg. 6.22 of 6.2

26

510(k) Number (if known):

Device Name:

Intended Use:

EV9F4 Curved array mechanical 3D/4D Transducer for use with : ACUSON X300 Diagnostic Uitrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
Abdominal
Intraoperative
(Note 6)
Intraoperative
Neurological
Pediatric
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
TransrectalPPPPPBMDCNote 2,3,4,5,7,8,9
TransvaginalPPPPPBMDCNote 2,3,4,5,7,8,9
Transurethral
Intravascular
Peripheral vessel
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Note 2 Ensemble tissue harmonic imaging

3D imaging Note 3

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

For example: abdominal, vascular Note 6

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Hogdon

ductive, Abdominal, a Radi

27

510(k) Number (if known):

Device Name:

Intended Use:

L13F5 3D/4D mechanical wobbler linear transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(Specify)Other
(Specify)
Ophthalmic
FetalPPPPPBMDCNote 2,3,4,5,7,8,9
AbdominalPPPPPBMDCNote 2,3,4,5,7,8,9
Intraoperative
(Note 6)
Intraoperative
Neurological
PediatricPPPPPBMDCNote 2,3,4,5,7,8,9
Small Organ
(Note 1)PPPPPBMDCNote 2,3,4,5,7,8,9
Neonatal CephalicPPPPPBMDCNote 2,3,4,5,7,8,9
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral vesselPPPPPBMDCNote 2,3,4,5,7,8,9
Laparoscopic
Musculo-skeletal
ConventionalPPPPPBMDCNote 2,3,4,5,7,8,9
Musculo-skeletal
SuperficialPPPPPBMDCNote 2,3,4,5,7,8,9
Other (specify)

N = new indication; P = previously cleared by FDA (K061946); E = added under Appendix E

Note 1 For example: breast, testes, thyroid, penis, prostate, etc.

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaqing

Note 4 B&W SieScape panoramic imaging

Power SieScape panoramic imaging Note 5

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

SieClear multi-view spatial compounding Note 8

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy Brogdon

oductive, Abdominal, and Divis 510(k) Number

Section 6

Diagnostic Ultrasound Indications for Use Form

Pp. 624

28

510(k) Number (if known):

Device Name:

Intended Use:

VF8-3 linear transducer for use with: ACUSON X300 Diagnostic Ultrasound Systems Diagnostic imaging or fluid flow analysis of the human body as follows:

| Clinical Application | Mode of Operation | | | | | | Combined
(Specify) | Other
(Specify) | | |
|----------------------------------|-------------------|---|---|-----|-----|------------------|-----------------------|--------------------|----------------------|------------------------------|
| | A | B | M | PWD | CWD | Color
Doppler | | | Amplitude
Doppler | Color
Velocity
Imaging |
| Ophthalmic | | | | | | | | | | |
| Fetal | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Abdominal | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Intraoperative
(Note 6) | | | | | | | | | | |
| Intraoperative
Neurological | | | | | | | | | | |
| Pediatric | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Small Organ
(Note 1) | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Neonatal Cephalic | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Transesophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral vessel | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Musculo-skeletal
Superficial | | N | N | N | | N | N | | BMDC | Note 2,3,4,5,7,8,9 |
| Other (specify) | | | | | | | | | | |

N = new indication; P = previously cleared by FDA; E = added under Appendix E

For example: breast, testes, thyroid, penis, prostate, etc. Note 1

Note 2 Ensemble tissue harmonic imaging

Note 3 3D imaging

Note 4 B&W SieScape panoramic imaging

Note 5 Power SieScape panoramic imaging

Note 6 For example: abdominal, vascular

Note 7 Contrast agent imaging

Note 8 SieClear multi-view spatial compounding

Tissue Equalization Technology Note 9

Note 10 Intracardiac imaging

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Nancy C. Brogdon
Prescription Use (Per 21 CFR 801.109)(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Devices
510(k) NumberK071036